人肺微塑料蓄积:肺癌与正常组织的差异特征
探索性研究比较10例肺癌与10例对照冷冻肺组织中微塑料负荷与特征,采用氢氧化钾消化结合拉曼显微光谱鉴定聚合物。所有标本均检出微塑料,癌组织中位颗粒数较高(39.0 vs 31.5 每约100 mg),但差异无统计学意义(OR 1.009/颗粒,95%CI 0.982-1.036)。聚丙烯、聚乙烯和聚对苯二甲酸乙二醇酯占78%,癌组织中聚丙烯和PET比例更高,纤维及<50 µm颗粒更常见。
要点
- 所有肺组织标本均检出微塑料,提示普遍暴露。
- 癌组织中位微塑料计数较高但无统计学意义。
- 癌组织以聚丙烯和PET比例更高、纤维及小颗粒更常见。
核心结论
- 肺癌组织与正常肺组织可能存在不同的微塑料特征,但微塑料负荷差异未达统计学意义。
研究设计与样本
- 探索性研究,比较癌性与非癌性肺组织的微塑料负荷与特征。
- 采用氢氧化钾消化后以拉曼显微光谱鉴定聚合物。
主要发现
- 所有标本均检出微塑料。
- 癌组织中位微塑料计数为39.0 vs 31.5 颗粒每约100 mg,差异无统计学意义(OR 1.009/颗粒,95%CI 0.982-1.036)。
- 聚丙烯、聚乙烯和聚对苯二甲酸乙二醇酯占颗粒的78%。
- 癌组织中聚丙烯和PET比例更高,纤维及<50 µm颗粒更常见。
临床怎么用
- 目前证据不足以将肺微塑料负荷用于肺癌风险评估或临床决策。
- 结果支持在更大样本、纵向研究中进一步验证微塑料与肺癌的关联。
局限性
- 微塑料负荷差异未达统计学意义。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Microplastics (MPs; <5 mm) are increasingly detected in human tissues, yet their relationship to lung cancer remains unclear. We conducted a pilot study comparing MP burden and characteristics in cancerous and non-cancerous lung tissue. Twenty cryopreserved samples (10 cancer, 10 controls) were processed using potassium hydroxide digestion, followed by Raman microspectroscopy for polymer identification. MPs were detected in all specimens. Cancer tissues showed a higher median MP count (39.0 vs 31.5 particles per ∼100 mg), although this difference was not statistically significant (OR 1.009 per particle, 95% CI 0.982-1.036). Polypropylene, polyethylene, and polyethylene terephthalate accounted for 78% of particles, with higher proportions of polypropylene and PET in cancer samples. Fibers predominated overall and were more frequent in cancer tissue, as were smaller particles (<50 µm). These findings suggest distinct microplastic signatures in lung cancer, supporting further investigation into their potential role in pulmonary carcinogenesis in larger, longitudinal studies.
引用
- Gholami M, Vaezi A, Firouzi A, et al. Microplastic accumulation in the human lung: distinct signatures in lung cancer vs normal tissue. Am J Respir Crit Care Med. 2026. PMID: 41738232. doi:10.1093/ajrccm/aamag081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。